EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Core–shell lycopene-loaded nanoparticle-modified intraocular lens for posterior capsule opacification prevention via mitochondrial homeostasis

Jian-Ying Liu, Shi-Chao Zhao, Jing-Shang Zhang, Jin-Fei Wei, Chun-Bo Dong, Hui-Cong Zheng, Tao Jiang, Meng Li, Ying-Yan Mao, Xiu-Hua Wan

Journal of Controlled Release · 2026-11 · 399 · 115292

DOI: 10.1016/j.jconrel.2026.115292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Jian-Ying Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. Hauptthemen laut MEDLINE: Capsule Opacification, Nanoparticles, Mitochondria, Lycopene. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Nova Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posterior capsule opacification (PCO) develops when residual lens epithelial cells (LECs) proliferate, migrate, and undergo epithelial-mesenchymal transition (EMT) after cataract surgery. Because mitochondrial dysfunction may promote EMT-associated cellular remodeling, modulation of mitochondrial quality control could provide a complementary strategy for PCO prevention. Lycopene (LYC) is a natural antioxidant capable of regulating mitochondrial homeostasis. Here, we developed a microfluidic-engineered LYC-eluting intraocular lens (IOL) modified with poly(lactic-co-glycolic acid) (PLGA)-shelled LYC-loaded liposome-core nanoparticles (LYC@Lip@PLGA-IOL). This dual-encapsulation design improved LYC formulation stability, reduced the initial burst release, and enabled sustained LYC release over a 14-day period in vitro. In SRA01/04 lens epithelial cells, LYC attenuated PI3K/AKT activation, activated mitophagy, restored mitochondrial membrane potential and ATP production, reduced reactive oxygen species (ROS) accumulation, and consequently inhibited EMT and migration. In a rabbit PCO model, LYC@Lip@PLGA-IOL reduced posterior capsule opacity, capsular thickening, and EMT-associated fibrotic remodeling, while exhibiting favorable ocular and systemic biocompatibility over 28 days. These findings support sustained local delivery of LYC as a mitophagy-activating strategy for restoring mitochondrial homeostasis and preventing PCO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capsule OpacificationNanoparticlesMitochondriaLycopeneLenses, IntraocularAntioxidantsAnimalsRabbitsHomeostasisPolylactic Acid-Polyglycolic Acid CopolymerEpithelial CellsHumansLiposomesCell LineEpithelial-Mesenchymal TransitionReactive Oxygen SpeciesDrug Liberation

Stichwörter der Autor:innen

Core–shell nanoparticlesIntraocular lensLycopeneMitochondrial homeostasisPosterior capsule opacification

Substanzen

LycopenePolylactic Acid-Polyglycolic Acid CopolymerAntioxidantsLiposomesReactive Oxygen Species

Autor:innen und Institutionen

  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
  • Beijing Key Laboratory of High-Entropy Energy Materials and Devices, Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China; School of Nanoscience and Engineering, University of Chi…
  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. Electronic address: drlimeng@mail.ccmu.edu.cn.
  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical Universi…
  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; Engineering Research Center of Ophthalmic Equipment and Materials, Ministry of Education, Capital Medical Universi…

Förderung

  • Beijing Nova Program
  • National Natural Science Foundation of China

Zitieren

APA

Liu, J. Y., Zhao, S. C., Zhang, J. S., Wei, J. F., Dong, C. B., Zheng, H. C., Jiang, T., Li, M., Mao, Y. Y., & Wan, X. H. (2026). Core–shell lycopene-loaded nanoparticle-modified intraocular lens for posterior capsule opacification prevention via mitochondrial homeostasis. Journal of Controlled Release, 399, 115292. https://doi.org/10.1016/j.jconrel.2026.115292

Vancouver

Liu JY, Zhao SC, Zhang JS, Wei JF, Dong CB, Zheng HC, et al. Core–shell lycopene-loaded nanoparticle-modified intraocular lens for posterior capsule opacification prevention via mitochondrial homeostasis. Journal of Controlled Release. 2026;399:115292. doi:10.1016/j.jconrel.2026.115292

BibTeX
@article{Liu2026,
  author = {Liu, Jian-Ying and Zhao, Shi-Chao and Zhang, Jing-Shang and Wei, Jin-Fei and Dong, Chun-Bo and Zheng, Hui-Cong and Jiang, Tao and Li, Meng and Mao, Ying-Yan and Wan, Xiu-Hua},
  title = {Core–shell lycopene-loaded nanoparticle-modified intraocular lens for posterior capsule opacification prevention via mitochondrial homeostasis},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {399},
  pages = {115292},
  doi = {10.1016/j.jconrel.2026.115292}
}
Kostenlos starten →